文献速递眼整形与眼眶

结膜鳞状细胞癌:秘鲁一家肿瘤医院中复发与转移的预后因素及临床病理特征

Conjunctival squamous cell carcinoma: prognostic factors for the recurrence and metastasis and clinicopathological characteristics at an oncological hospital in Peru.
PubMed 文献 · Br J Ophthalmol · 2019-10-11

该研究为纵向回顾性研究,纳入秘鲁一家肿瘤医院176例连续诊断的结膜鳞状细胞癌患者,描述其临床病理特征并分析复发与转移的预后因素。结果显示仅12.5%肿瘤≤5毫米,T3期最常见(31.3%),最常行眶内容物剜除术(38.6%),复发率6.8%、转移率8.0%,所评估的预后因素均无统计学意义。

要点

  • 176例连续结膜鳞状细胞癌患者中仅12.5%肿瘤最大径≤5毫米,T3期占31.3%。
  • 组织病理以高分化浸润型最多(40.9%),最常行的初始治疗为眶内容物剜除术(38.6%)。
  • 复发率为6.8%,转移率为8.0%,所评估的预后因素均无统计学意义。

核心结论

  • 这是拉丁美洲规模最大的结膜鳞状细胞癌患者研究,高比例患者为高级别组织病理、晚期TNM分期并接受眶内容物剜除等根治性治疗。
  • 平均复发率与其他已发表研究相似,并描述了文献中报道较少的转移率。

研究设计与样本

  • 纵向回顾性研究,纳入176例连续诊断的结膜鳞状细胞癌患者。
  • 评估社会人口学与临床特征,采用Kaplan-Meier曲线和Cox回归分析复发与转移的预后因素。

主要发现

  • 仅12.5%的患者肿瘤最大径≤5毫米。
  • 组织病理类型中高分化浸润型比例最高,为40.9%。
  • TNM分期中T3期最常见,占31.3%。
  • 最常行的初始治疗为眶内容物剜除术,占38.6%。
  • 复发率为6.8%,转移率为8.0%;年生存率为7%,年转移率为6%;5年后复发相关生存率为11%,5年后转移率为14%;所评估的预后因素均无统计学意义。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND/AIMS: Conjunctival squamous cell carcinoma (CSCC) is the most frequent malignant tumour of the conjunctiva, with scarce recurrence and infrequent metastasis. The purpose of this study is to describe the clinical and pathological characteristics of this neoplasm and to identify the prognostic factors for recurrence and metastasis in a cancer hospital in Peru. MATERIALS AND METHOD: A longitudinal, retrospective study of 176 consecutive patients diagnosed with SCC of the conjunctiva. Sociodemographic and clinical characteristics were evaluated. In addition, Kaplan-Meier curves were performed, and Cox regression was used to determine prognostic factors for recurrence and metastasis over time. RESULT: Only 12.5% presented tumour size ≤5 mm. The highest proportion according to the histopathological type was the well-differentiated infiltrative forms (40.9%), and according to tumour, node, metastases (TNM), stage T3 was the most frequent (31.3%). The most performed initial treatment was orbital exenteration (38.6%). The proportion of recurrence was 6.8% and 8.0% for metastasis. The annual survival rate was 7% and the annual metastasis rate was 6%; for recurrence after 5 years, the survival rate was 11% and the metastasis rate was 14%. No prognostic factor evaluated was significant. CONCLUSION: This is the most extensive patient study in Latin America with CSCC, with a high proportion of advanced histopathological grade, TNM stages, and radical treatments such as exenteration. Recurrence rates on average are similar to other reported studies, and it describes the rates of metastasis that have been poorly described in the literature.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Cruzado-Sanchez D, Tellez WA, Villarreal-Aguilar B, et al. Conjunctival squamous cell carcinoma: prognostic factors for the recurrence and metastasis and clinicopathological characteristics at an oncological hospital in Peru. Br J Ophthalmol. 2019. PMID: 31604702. doi:10.1136/bjophthalmol-2019-314058

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。